Involvement of MarR and YedS in carbapenem resistance in a clinical isolate of Escherichia coli from China

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 4, 2013, Pages 1935-1937

  Warner, Douglas M ^a,b   Yang, Qiwen ^d   Duval, Valérie ^a,b   Chen, Minjun ^d   Xu, Yingchun ^d   Levy, Stuart B ^a,b,c  

^a Ctr Adaptation Genet Drug Resist   (United States)

^b Department of Molecular Biology and Microbiology ^*  (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; ERTAPENEM; IMIPENEM; MEROPENEM; OUTER MEMBRANE PROTEIN; PROTEIN MARR; PROTEIN YEDS; TRANSFER RNA; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHINA; ESCHERICHIA COLI; EXPRESSION VECTOR; GENE EXPRESSION; GENE MUTATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

CARBAPENEMS; CHINA; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL; MOLECULAR SEQUENCE DATA; REPRESSOR PROTEINS;

EID: 84875169408     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02445-12     Document Type: Article

References (27)

1. Chia JH, Siu LK, Su LH, Lin HS, Kuo AJ, Lee MH, Wu TL. 2009. Emergence of carbapenem-resistant Escherichia coli in Taiwan: resistance due to combined CMY-2 production and porin deficiency. J. Chemother. 21:621- 626.
2. Hsueh PR, Hoban DJ, Carmeli Y, Chen SY, Desikan S, Alejandria M, Ko WC, Binh TQ. 2011. Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region. J. Infect. 63:114 -123.
3. Yang Q, Wang H, Sun H, Chen H, Xu Y, Chen M. 2010. Phenotypic and genotypic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems: results from large hospital-based surveillance studies in China. Antimicrob. Agents Chemother. 54:573-577.
4. Goren MG, Navon-Venezia S, Chmelnitsky I, Carmeli Y. 2010. Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008. Antimicrob. Agents Chemother. 54:2687-2691.
5. Queenan AM, Bush K. 2007. Carbapenemases: the versatile β-lactamases. Clin. Microbiol. Rev. 20:440-458.
6. Oteo J, Delgado-Iribarren A, Vega D, Bautista V, Rodriguez MC, Velasco M, Saavedra JM, Perez-Vazquez M, Garcia-Cobos S, Martinez-Martinez L, Campos J. 2008. Emergence of imipenem resistance in clinical Escherichia coli during therapy. Int. J. Antimicrob. Agents 32:534-537.
7. Poirel L, Heritier C, Spicq C, Nordmann P. 2004. In vivo acquisition of high-level resistance to imipenem in Escherichia coli. J. Clin. Microbiol. 42:3831-3833.
8. Stapleton PD, Shannon KP, French GL. 1999. Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4 β-lactamase production and loss of an outer membrane protein. Antimicrob. Agents Chemother. 43:1206 -1210.
9. Cohen SP, Hachler H, Levy SB. 1993. Genetic and functional analysis of the multiple antibiotic resistance (mar) locus in Escherichia coli. J. Bacteriol. 175:1484 -1492.
10. Alekshun MN, Levy SB, Mealy TR, Seaton BA, Head JF. 2001. The crystal structure of MarR, a regulator of multiple antibiotic resistance, at 2.3 A resolution. Nat. Struct. Biol. 8:710 -714.
11. Seoane AS, Levy SB. 1995. Characterization of MarR, the repressor of the multiple antibiotic resistance (mar) operon in Escherichia coli. J. Bacteriol. 177:3414 -3419.
12. Cohen SP, Levy SB, Foulds J, Rosner JL. 1993. Salicylate induction of antibiotic resistance in Escherichia coli: activation of the mar operon and a mar-independent pathway. J. Bacteriol. 175:7856 -7862.
13. Li XZ, Nikaido H. 2004. Efflux-mediated drug resistance in bacteria. Drugs 64:159 -204.
14. Okusu H, Ma D, Nikaido H. 1996. AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multipleantibiotic- resistance (Mar) mutants. J. Bacteriol. 178:306 -308.
15. Cohen SP, McMurry LM, Levy SB. 1988. marA locus causes decreased expression of OmpF porin in multiple-antibiotic-resistant (Mar) mutants of Escherichia coli. J. Bacteriol. 170:5416 -5422.
16. Chubiz LM, Rao CV. 2011. Role of the mar-sox-rob regulon in regulating outer membrane porin expression. J. Bacteriol. 193:2252-2260.
17. Alekshun MN, Levy SB. 1999. Characterization of MarR superrepressor mutants. J. Bacteriol. 181:3303-3306.
18. Studier FW, Rosenberg AH, Dunn JJ, Dubendorff JW. 1990. Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol. 185:60-89.
19. Maneewannakul K, Maneewannakul S, Ippen-Ihler K. 1992. Sequence alterations affecting F plasmid transfer gene expression: a conjugation system dependent on transcription by the RNA polymerase of phage T7. Mol. Microbiol. 6:2961-2973.
20. Miller JH. 1972. Experiments in molecular genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
21. Simons RW, Houman F, Kleckner N. 1987. Improved single and multicopy lac-based cloning vectors for protein and operon fusions. Gene 53: 85-96.
22. Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, Baba M, Datsenko KA, Tomita M, Wanner BL, Mori H. 2006. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol. Syst. Biol 2:2006.0008.
23. Ruiz C, Levy SB. 2010. Many chromosomal genes modulate MarAmediated multidrug resistance in Escherichia coli. Antimicrob. Agents Chemother. 54:2125-2134.
24. Nicoloff H, Perreten V, McMurry LM, Levy SB. 2006. Role for tandem duplication and Lon protease in AcrAB-TolC-dependent multiple antibiotic resistance (Mar) in an Escherichia coli mutant without mutations in marRAB or acrRAB. J. Bacteriol. 188:4413- 4423.
25. Warner DM, Levy SB. 2012. SoxS increases the expression of the zinc uptake system ZnuACB in an Escherichia coli murine pyelonephritis model. J. Bacteriol. 194:1177-1185.
26. Casaz P, Garrity-Ryan LK, McKenney D, Jackson C, Levy SB, Tanaka SK, Alekshun MN. 2006. MarA, SoxS and Rob function as virulence factors in an Escherichia coli murine model of ascending pyelonephritis. Microbiology 152:3643-3650.
27. Duval V, Nicoloff H, Levy SB. 2009. Combined inactivation of lon and ycgE decreases multidrug susceptibility by reducing the amount of OmpF porin in Escherichia coli. Antimicrob. Agents Chemother. 53:4944-4948.